Anzeige
Mehr »
Login
Freitag, 19.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Goldaktie: Eine Erfolgsgeschichte, die seinesgleichen sucht, startet gerade richtig durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
57 Leser
Artikel bewerten:
(0)

Research and Markets - Global Hemodynamic Monitoring Market 2016-2020 - Key Vendors are Edwards Lifesciences, ICU Medical, LiDCO & PULSION Medical Systems SE

DUBLIN, May 12, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Hemodynamic Monitoring Market 2016-2020" report to their offering.

The global hemodynamic monitoring devices market to grow at a CAGR of 6.44% during the period 2016-2020.

Global Hemodynamic Monitoring Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Funding from government sources and companies helps increase the sales of hemodynamic monitors. In the US, the NIH funds its Vascular Interventions/Innovations and Therapeutic Advances Program that is involved in accelerating the development of diagnostic and therapeutic modalities. The program helps develop various tests for the novel pulmonary arterial hypertension therapy by combining hemodynamic monitoring with advanced software and technology.

According to the report, demand in disease treatment and critical care is one of the major factors driving the growth of this market globally. People of all ages, particularly infants, women, and older people are susceptible to various diseases. In infants, congenital heart disease is one of the major disorders. This is due to the occurrence of structural defects during the development of the heart in the fetal stage. Physicians use pulse oximetry to detect this disease in infants. The procedure involves the measurement of oxygen levels in the blood. Low oxygen levels in the blood of infants signify the presence of heart problems.

Further, the report states that risks associated with invasive hemodynamic monitoring have led to the decline in the use of associated devices, decreasing their market share.

Key vendors

- Edwards Lifesciences Corp. - ICU Medical Inc. - LiDCO Ltd. - PULSION Medical Systems SE

Other prominent vendors

- Cheetah Medical - Deltex Medical Group - FUJIFILM SonoSite - GE Healthcare - Mindray - Nihon Kohden - NImedical - Noninvasive Medical Technologies - Osypka Medical - Philips Healthcare - Schwarzer Cardiotek - Tensys Medical - Uscom

Key Topics Covered:

Part 01: Executive summary

Part 02: Scope of the report

Part 03: Market research methodology

Part 04: Introduction

Part 05: Market landscape

Part 06: Market segmentation by product

Part 07: Market segmentation by application

Part 08: Market segmentation by end-user

Part 09: Geographical segmentation

Part 10: Market drivers

Part 11: Impact of drivers

Part 12: Market challenges

Part 13: Impact of drivers and challenges

Part 14: Market trends

Part 15: Vendor landscape

Part 16: Appendix

For more information visit http://www.researchandmarkets.com/research/2nd3zx/global

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.